# Baclofen for Smoking Cessation in a Non-Psychiatric Population

> **NCT01228994** · PHASE2 · TERMINATED · sponsor: **Centre for Addiction and Mental Health** · enrollment: 6 (actual)

## Conditions studied

- Nicotine Dependence

## Interventions

- **DRUG:** Baclofen 30 mg/day
- **DRUG:** placebo pill
- **DRUG:** Baclofen 60 mg/day

## Key facts

- **NCT ID:** NCT01228994
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-10
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** The study was terminated because of difficulties recruiting subjects.
- **Last updated:** 2013-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01228994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01228994, "Baclofen for Smoking Cessation in a Non-Psychiatric Population". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01228994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*